Skip to main content

Longitudinal Multimodal Transformer Integrating Imaging and Latent Clinical Signatures from Routine EHRs for Pulmonary Nodule Classification.

Posted by on Wednesday, December 13, 2023 in Longitudinal Imaging, Lung Cancer, Multimodal.

Thomas Z. Li, John M. Still, Kaiwen Xu, Ho Hin Lee, Leon Y. Cai, Aravind R. Krishnan, Riqiang Gao, Mirza S. Khan, Sanja Antic, Michael Kammer, Kim L. Sandler, Fabien Maldonado, Bennett A. Landman, Thomas A. Lasko.

 

Abstract

The accuracy of predictive models for solitary pulmonary nodule (SPN) diagnosis can be greatly increased by incorporating repeat imaging and medical context, such as electronic health records (EHRs). However, clinically routine modalities such as imaging and diagnostic codes can be asynchronous and irregularly sampled over different time scales which are obstacles to longitudinal multimodal learning. In this work, we propose a transformer-based multimodal strategy to integrate repeat imaging with longitudinal clinical signatures from routinely collected EHRs for SPN classification. We perform unsupervised disentanglement of latent clinical signatures and leverage time-distance scaled self-attention to jointly learn from clinical signatures expressions and chest computed tomography (CT) scans. Our classifier is pretrained on 2,668 scans from a public dataset and 1,149 subjects with longitudinal chest CTs, billing codes, medications, and laboratory tests from EHRs of our home institution. Evaluation on 227 subjects with challenging SPNs revealed a significant AUC improvement over a longitudinal multimodal baseline (0.824 vs 0.752 AUC), as well as improvements over a single cross-section multimodal scenario (0.809 AUC) and a longitudinal imaging-only scenario (0.741 AUC). This work demonstrates significant advantages with a novel approach for co-learning longitudinal imaging and non-imaging phenotypes with transformers.

qual copy

Figure 3. This is a control subject who developed a lesion over 3 months (a), to which the imaging-only approaches assigned a cancer probability of 0.4 (c). However, the subject’s highest expressed clinical signature at the 3-month mark was a new pattern of bacterial pneumonia (b), offering to the model a benign explanation of an image that it would otherwise be less correctly confident in.